Xylem (NYSE:XYL) PT Raised to $135.00 at Mizuho

Xylem (NYSE:XYL) had its price target increased by equities research analysts at Mizuho from $110.00 to $135.00 in a research report issued to clients and investors on Friday, Benzinga reports. The firm presently has a “neutral” rating on the industrial products company’s stock. Mizuho’s target price would indicate a potential downside of 1.61% from the company’s previous close.

XYL has been the subject of a number of other reports. Robert W. Baird upped their price objective on shares of Xylem from $151.00 to $155.00 and gave the company an “outperform” rating in a research report on Friday. Raymond James raised shares of Xylem from an “underperform” rating to a “market perform” rating in a research report on Thursday, January 4th. Stifel Nicolaus upped their price objective on shares of Xylem from $136.00 to $150.00 and gave the company a “buy” rating in a research report on Wednesday, February 7th. Royal Bank of Canada upped their price objective on shares of Xylem from $140.00 to $145.00 and gave the company an “outperform” rating in a research report on Wednesday, February 7th. Finally, BNP Paribas assumed coverage on shares of Xylem in a research report on Tuesday, March 12th. They issued an “outperform” rating and a $150.00 price objective for the company. Five research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $140.70.

Xylem Stock Up 0.9 %

Shares of Xylem stock opened at $137.21 on Friday. The company has a fifty day moving average price of $128.64 and a 200 day moving average price of $115.36. The company has a current ratio of 1.67, a quick ratio of 1.30 and a debt-to-equity ratio of 0.19. Xylem has a twelve month low of $87.59 and a twelve month high of $138.46. The stock has a market cap of $33.26 billion, a price-to-earnings ratio of 48.83, a price-to-earnings-growth ratio of 2.67 and a beta of 1.08.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Thursday, May 2nd. The industrial products company reported $0.90 earnings per share for the quarter, topping analysts’ consensus estimates of $0.84 by $0.06. Xylem had a net margin of 8.34% and a return on equity of 8.95%. The firm had revenue of $2.03 billion during the quarter, compared to analysts’ expectations of $2 billion. During the same period in the prior year, the company earned $0.72 EPS. The firm’s revenue was up 40.4% on a year-over-year basis. Equities research analysts forecast that Xylem will post 4.2 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In related news, SVP Franz Cerwinka sold 2,408 shares of the stock in a transaction dated Thursday, February 8th. The shares were sold at an average price of $121.79, for a total transaction of $293,270.32. Following the sale, the senior vice president now owns 11,750 shares in the company, valued at $1,431,032.50. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CAO Geri-Michelle Mcshane sold 1,000 shares of the stock in a transaction dated Tuesday, February 20th. The stock was sold at an average price of $122.89, for a total transaction of $122,890.00. Following the sale, the chief accounting officer now owns 2,935 shares in the company, valued at approximately $360,682.15. The disclosure for this sale can be found here. 0.27% of the stock is owned by company insiders.

Institutional Investors Weigh In On Xylem

Institutional investors and hedge funds have recently bought and sold shares of the business. Vanguard Group Inc. increased its stake in shares of Xylem by 0.7% in the fourth quarter. Vanguard Group Inc. now owns 28,048,996 shares of the industrial products company’s stock valued at $3,207,683,000 after purchasing an additional 187,847 shares during the period. Morgan Stanley increased its stake in shares of Xylem by 11.5% in the third quarter. Morgan Stanley now owns 4,528,905 shares of the industrial products company’s stock valued at $412,267,000 after purchasing an additional 466,911 shares during the period. Invesco Ltd. increased its stake in shares of Xylem by 35.1% in the third quarter. Invesco Ltd. now owns 4,182,821 shares of the industrial products company’s stock valued at $380,762,000 after purchasing an additional 1,086,102 shares during the period. Royal Bank of Canada increased its stake in shares of Xylem by 10.6% in the third quarter. Royal Bank of Canada now owns 3,408,200 shares of the industrial products company’s stock valued at $310,249,000 after purchasing an additional 327,383 shares during the period. Finally, Baillie Gifford & Co. increased its stake in shares of Xylem by 2.3% in the fourth quarter. Baillie Gifford & Co. now owns 3,066,639 shares of the industrial products company’s stock valued at $350,701,000 after purchasing an additional 69,619 shares during the period. Institutional investors and hedge funds own 87.96% of the company’s stock.

About Xylem

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.